Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Quality of Life
100%
Polyneuropathy
100%
Physical Function
100%
Life Functioning
100%
Vutrisiran
100%
Hereditary Transthyretin Amyloidosis
100%
Least Mean Square
62%
Change from Baseline
62%
Placebo
50%
ATTR Amyloidosis
50%
Diabetic Neuropathy
37%
Norfolk Quality of Life
37%
Disability Index
37%
Placebo Groups
25%
Quality Measures
25%
Helios
25%
RNA Therapeutics
25%
Modified Body Mass Index
25%
EuroQol-Visual Analogue Scale
25%
Early Treatment
12%
Karnofsky Performance Status
12%
Visual Analog Scale
12%
Disease-associated
12%
Early Disease
12%
Amyloidosis
12%
Early Diagnosis
12%
Domain Scores
12%
Progressive Disease
12%
Rasch
12%
Trial Registration
12%
Multiple Measures
12%
Transthyretin
12%
Fatal Infection
12%
Rapid Deterioration
12%
Apollo
12%
Hereditary Transthyretin
12%
Patisiran
12%
ATTRv
12%
Registration number
12%
Patient Quality of Life
12%
10-meter Walk Test
12%
Significant Clinical Benefit
12%
Nursing and Health Professions
Amyloidosis
100%
Polyneuropathy
100%
Transthyretin
100%
Quality of Life
100%
Physical Function
100%
Placebo
85%
Least Squares Method
71%
Diabetic Neuropathy
42%
Body Mass
28%
Visual Analog Scale
28%
Diseases
28%
RNAi Therapeutics
28%
Early Diagnosis
14%
Deterioration
14%
Walk Test
14%
Karnofsky Performance Status
14%
Efficacy
14%
Accident Prevention
14%
Patisiran
14%
Medicine and Dentistry
Quality of Life
100%
Amyloidosis
100%
Polyneuropathy
100%
Transthyretin
100%
Placebo
85%
Least Squares Method
71%
Diabetic Neuropathy
42%
Body Mass Index
28%
Visual Analog Scale
28%
RNAi Therapeutics
28%
Diseases
28%
Deterioration
14%
Karnofsky Performance Status
14%
Early Diagnosis
14%
Walk Test
14%
Patisiran
14%
Neuroscience
Amyloidosis
100%
Polyneuropathy
100%
Transthyretin
100%
Quality of Life
100%
Placebo
85%
Diabetic Neuropathy
42%
Body Mass Index
28%
RNAI
28%
Patisiran
14%
Immunology and Microbiology
Amyloidosis
100%
Body Mass
33%
RNAI
33%
Pretreatment
16%
Psychology
Quality of Life
100%
Body Mass Index
28%
Visual Analog Scale
28%